BrightHeart gains new clearance for heart defect detection platform
BrightHeart has gained a further 510(k) clearance from the FDA for its AI-based prenatal congenital heart defect (CHD) screening platform. The post BrightHeart gains new clearance for heart defect detection platform appeared first on Medical Device Network.
BrightHeart has gained a further 510(k) clearance from the FDA for its AI-based prenatal congenital heart defect (CHD) screening platform.
The post BrightHeart gains new clearance for heart defect detection platform appeared first on Medical Device Network.
